The putative Plasmodium translocon of exported proteins (PTEX) is essential for transport of malarial effector proteins across a parasite-encasing vacuolar membrane into host erythrocytes, but the mechanism of this process remains unknown. Here we show that PTEX is a bona fide translocon by determining structures of the PTEX core complex at near-atomic resolution using cryo-electron microscopy. We isolated the endogenous PTEX core complex containing EXP2, PTEX150 and HSP101 from Plasmodium falciparum in the 'engaged' and 'resetting' states of endogenous cargo translocation using epitope tags inserted using the CRISPR-Cas9 system. In the structures, EXP2 and PTEX150 interdigitate to form a static, funnel-shaped pseudo-seven-fold-symmetric protein-conducting channel spanning the vacuolar membrane. The spiral-shaped AAA+ HSP101 hexamer is tethered above this funnel, and undergoes pronounced compaction that allows three of six tyrosine-bearing pore loops lining the HSP101 channel to dissociate from the cargo, resetting the translocon for the next threading cycle. Our work reveals the mechanism of P. falciparum effector export, and will inform structure-based design of drugs targeting this unique translocon. 7 0 | N A t U r e | V O l 5 6 1 | 6 S e P t e M B e r 2 0 1 8
Malaria has devastated major civilizations since the dawn of humanity, and remains a considerable burden to society; it is responsible for more than 200 million cases and nearly half a million deaths each year 1 . This infectious disease is caused by Plasmodium parasites, which invade and reproduce within human erythrocytes, inducing the clinical symptoms of malaria 2, 3 . These parasites export hundreds of effector proteins that extensively remodel host erythrocytes, which have limited capacity for biosynthesis [4] [5] [6] . Collectively known as the exportome, these proteins create the infrastructure necessary to import nutrients, export waste, and evade splenic clearance of infected erythrocytes 7 . Most of these proteins bear a five-residue motif called the Plasmodium export element (PEXEL) [8] [9] [10] . The malaria parasite conceals itself inside a parasitophorous vacuole, which is derived from invagination of the host cell plasma membrane during invasion 11 (Fig. 1a ). Following secretion into the parasitophorous vacuole, proteins destined for export are unfolded and transported across the parasitophorous vacuole membrane (PVM) into the host cell in an ATP-dependent process 12, 13 . To accomplish this, it has been hypothesized that the parasite has evolved a unique membrane protein complex, the Plasmodium translocon of exported proteins (PTEX) 14 . PTEX is the only known point of entry to the host cell for exported proteins and is therefore an attractive drug target, as disrupting PTEX blocks delivery of key virulence determinants and induces parasite death 15, 16 .
PTEX has been proposed to be a membrane protein complex larger than 1.2 MDa, with a core composed of the HSP101 ATPase and two novel proteins, PTEX150 and EXP2 14, 17 (Fig. 1a ). HSP101 belongs to the class 1 Clp/HSP100 family of AAA+ ATPases, PTEX150 has no known homologues beyond the Plasmodium genus, and EXP2 is a PVM protein 14, 18 that is conserved among vacuole-dwelling apicomplexans 19 . All three core components are essential for protein export and parasite survival 15, 16, 20 . A model of PTEX-mediated translocation has been proposed, in which HSP101 unfolds and threads proteins through an oligomeric EXP2 transmembrane channel spanning the PVM, with PTEX150 having a structural role between EXP2 and HSP101 [14] [15] [16] [17] .
However, without structural information, the global architecture of PTEX, the stoichiometry of its components and its molecular mechanism have remained unclear.
In this study, we purify PTEX directly from the human malaria parasite P. falciparum and determine the structure of the complex in multiple functional states at near-atomic resolution using cryo-electron microscopy (cryo-EM). Our atomic models reveal the architecture and mechanism of this unique translocon and open a path towards development of novel therapeutics against this promising anti-malarial drug target.
Architecture of the PTEX core complex
To purify PTEX from P. falciparum, we used CRISPR-Cas9 editing to introduce a 3×Flag epitope tag on the C terminus of endogenously expressed HSP101 (Extended Data Fig. 1a -c) and purified the endogenously assembled PTEX core complex directly from P. falciparum cultured in human erythrocytes (Extended Data Fig. 1d-f ). Cryo-EM analysis yielded two distinct conformations of PTEX particles, one extended (195 Å) and the other compact (175 Å) ( Fig. 1b , c, Extended Data Table 1 ). Endogenous cargo polypeptide densities are visible in the central pore of HSP101 in both structures (Fig. 1b , c, Extended Data Figs. 2, 3 ). On the basis of differences in the arrangement of HSP101 subunits relative to the cargo between the two conformations, we designated them as the 'engaged' and 'resetting' states, respectively. Both maps are at near-atomic resolution, varying from 3.0-3.6 Å in the transmembrane and core regions to 5-8 Å in the periphery (Fig. 1b , c, Extended Data Fig. 4 ). As most regions exhibit clear sidechain densities throughout both maps (Fig. 1b , c, Extended Data Fig. 5 , Supplementary Videos 1, 2) we were able to build de novo atomic models of the three constituent proteins for both conformational states ( Fig. 1d, e ). Each model contains 20 subunits with 6,898 modelled amino acid residues. Models of all subunits were built independently, as their conformations varied.
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Both structures show that PTEX is a tripartite membrane protein complex with a 6:7:7 stoichiometry and a calculated mass of 1.6 MDa, composed of a hexameric HSP101 protein-unfolding motor tethered to a PVM-spanning, pseudosymmetric funnel formed by seven protomers of EXP2 interdigitating with seven protomers of PTEX150 ( Fig. 1d -k, Supplementary Video 3). Two transiently associated 21 accessory proteins, PTEX88 and TRX2 14 , are not seen in our structures. At the PVM, each EXP2 monomer contributes a single transmembrane helix to form a seven-fold (C7)-symmetric protein-conducting channel spanning the membrane (Fig. 1j , k). Six HSP101 protomers are tethered on top of the PTEX150−EXP2 funnel in a hexameric right-handed spiral, with a gap between the bottom-most and top-most protomers ( Fig. 1f , g, Supplementary Video 4). The HSP101 hexamer is oriented such that a single unbroken channel extends from the top of the HSP101 hexamer to the bottom of the heptameric EXP2 transmembrane pore ( Fig. 1l -n, Extended Data Fig. 2d ). The most constricted point along the channel occurs in HSP101, measuring 4 Å and 10 Å in diameter in the engaged and resetting states, respectively (Fig. 1l ). The seventh EXP2 and PTEX150 protomers are situated under the gap between HSP101 protomers 1 and 6, accommodating the remarkable symmetry mismatch between the asymmetric HSP101 hexamer and the pseudo-seven-fold-symmetric PTEX150-EXP2 tetradecamer ( Fig. 1f -k, Extended Data Fig. 2e -j). Analyses of our PTEX150 and EXP2 structures with four commonly used structural similarity search programs [22] [23] [24] [25] found no consistent structural similarities to any known proteins, including the pore-forming toxin haemolysin E, with which EXP2 was previously speculated to share structural homology 14 . Below, we describe the structural details of the individual proteins in the engaged state, followed by a comparison of the two states that suggests a mechanism of translocation.
EXP2 forms a protein-conducting channel across PVM
Residues G27-S234 of EXP2 are well-resolved in our structure, accounting for 80% of the mature protein (Extended Data Fig. 6a ).
EXP2 is a single-pass transmembrane protein consisting of a kinked 60 Å N-terminal transmembrane helix followed by a globular body domain and ending in an assembly domain composed of a linker helix followed by the assembly strand ( Fig. 2a, b ). The body domain contains five helices, B1−B5, which are stabilized by an intraprotomer C113− C140 disulphide bond ( Fig. 2c ).
Seven EXP2 protomers (which we labelled A−G) oligomerize to form a funnel-shaped C7-pseudosymmetric 216-kDa heptamer spanning the PVM (Fig. 2d, e ). The transmembrane domain and body helices B1-B3 are symmetric throughout all seven protomers (Extended Data Fig. 3a, b ). This symmetry is broken by inter-protomer conformational variations in body helices B4-B5 and the assembly domain, which stretch upwards in some protomers to maintain contacts with the asymmetric HSP101 hexamer located above the EXP2 funnel. This variation is most pronounced in EXP2 protomers F and G (Extended Data Fig. 3a, b ).
In the EXP2 heptamer, the amphipathic transmembrane helices twist slightly around each other, creating a 37 Å-long C7-symmetric protein-conducting channel that spans the PVM and forms the stem of the funnel (Fig. 2d, e ). The membrane-facing surface of the EXP2 channel is coated with hydrophobic residues, whereas the inner surface is lined with charged and polar residues, creating an aqueous pore ( Fig. 2e ). The body domains, positioned in a wider ring on top of the transmembrane channel on the vacuolar face of the PVM, form the mouth of the funnel. This orientation is consistent with previous analyses of EXP2 topology 14, 20 . Furthermore, a detergent belt is clearly visible in 2D class averages and density maps (Extended Data Figs. 7, 8) , defining the residues in the transmembrane domain that would be buried in the PVM. A ring of positively charged residues where the stem meets the mouth of the funnel is positioned where it can interact with the negatively charged phosphates of the membrane surface (Extended Data Fig. 8a ).
PTEX150 forms an adaptor between HSP101 and EXP2
Of the 993 residues in PTEX150, S668−D823 are well-resolved in the structure, and form a hook with a shaft (Fig. 3a, b ). The hook Article reSeArcH domain consists of three short helices (H1-H3), which are connected by several long loops. Directly N-terminal and C-terminal to the hook domain, the shaft is composed of proximal and distal shaft domains ( Fig. 3a, b ). The remaining 80% of PTEX150-not visible in our structures-is predicted to be intrinsically disordered (in this region the average disorder tendency score in IUPred 26, 27 is 0.83, with scores above 0.5 indicating disorder), unlike the rigid structured core of PTEX150(S668-D823) (with an average disorder tendency score of 0.42, indicating ordered structure), suggesting that this 80% of the protein is too mobile to be observed and may be flexibly arranged outside the stable PTEX core.
Seven PTEX150(S668-D823) hooks (which we labelled a-g) oligomerize, forming a flange-shaped C7-pseudosymmetric heptamer ( Fig. 3c ) that fits into the mouth of the EXP2 channel. Each hook lies in the groove between adjacent EXP2 body domains, and the tip of the hook curls down into the mouth of the EXP2 pore ( Fig. 3d ). A vertical, heptameric ring of H2 helices sits in the mouth of the EXP2 funnel, forming a conduit between the hexameric HSP101 and heptameric EXP2 central pores (Extended Data Fig. 2g -j). In this way, PTEX150(S668-D823) serves as an adaptor between HSP101 and EXP2, providing a continuous protected path for unfolded cargo.
Endogenous cargo is observed in the channel of HSP101
Class 1 Clp-HSP100 AAA+ ATPases are highly conserved hexameric protein unfoldases that are associated with diverse functions; they are known to thread polymeric substrates through a central pore 28, 29 . HSP101 is a 598-kDa hexamer, exemplifying the canonical class 1 Clp-HSP100 domain architecture 30, 31 , with a substrate-binding N-terminal domain 32 followed by two AAA+ nucleotide-binding domains (NBD1 and NBD2), each containing a cargo-binding pore loop (L1 and L2, respectively) that extends into the central pore ( Fig. 4a, b ). Additionally, HSP101 contains a C-terminal domain and a coiled-coil middle domain insertion in the C-terminal end of NBD1 ( Fig. 4a, b ).
Unlike class 2 HSP100s 33 , class 1 HSP100s form three-tiered hexamers, in which the N-terminal domains, NBD1s and NBD2s form the top, middle and bottom tiers, respectively 30, 31 . In our engaged state structure, the NBD1 and NBD2 tiers are arranged in a right-handed ascending spiral 30, 31, 34 (Fig. 4c ). A layer of weaker density above the NBD1 tier may correspond to the N-terminal domains, which are likely to be dynamic (Extended Data Fig. 8b ). The middle domains encircle the upper NBD1 tier. The central pore of the spiral is lined with pore loops bearing tyrosines in a spiral staircase pattern. The tyrosine sidechain densities intercalate with a 45 Å-long density that is clearly visible in the middle of the chaperone pore ( Fig. 4c, d , Supplementary Video 5), which closely resembles unfolded cargo polypeptide densities reported in recently published cryo-EM structures of homologous HSP100s bound to cargo 31, 33 (Extended Data Fig. 2a, d ). The unfolded PTEX cargo polypeptide chain modelled into this 45 Å density matches very closely (root mean square deviation (r.m.s.d.) of 1.09-1.25 Å) with the unfolded cargo polypeptides in these cargo-bound homologue structures (Extended Data Fig. 2a -c).
Key interactions for PTEX assembly and function
The three PTEX components share extensive binding interfaces; here we describe the two most noteworthy interactions. In each EXP2 protomer A-F, the assembly strand augments the C-terminal domain β-sheet in the HSP101 protomer situated directly above it ( Fig. 5a, b ). Protomer G occupies the space below the gap between HSP101 protomers 1 and 6 ( Fig. 1f-k ). This hydrogen bond interaction tethers the HSP101 hexamer to the transmembrane funnel, positioning the central pore exit directly above the entrance to the PTEX150-EXP2 pore. We hypothesized that this interaction is essential for assembly of the PTEX core complex, and that the complex must be stably assembled to be active. We tested this using genetic functional complementation in live P. falciparum. 
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Knockdown of EXP2 produces a lethal defect in P. falciparum growth and export that can be rescued by a mutant version of EXP2 that lacks the C-terminal 54 residues 20 . Therefore, the amino acids immediately following the assembly strand are not essential for PTEX function. However, complementation with a version of EXP2 that lacks an additional 12 residues, removing the assembly strand, failed to rescue these phenotypes ( Fig. 5c-f ). These results demonstrate that the EXP2 assembly strand is critical to PTEX function, consistent with an essential role for it in docking the HSP101 unfoldase to the EXP2 membrane channel to facilitate translocation.
A strong, albeit lower resolution claw-shaped density extends from the end of each modelled PTEX150(S668-D832) shaft to the HSP101 middle domain above, terminating in a three-turn helix that rests on the midpoint of the middle domain. This helix forms a strong interaction with Y488 and Y491 of HSP101 in claws a-e (Extended Data Fig. 8d e), but is not visible in claw f in the engaged state. Claw g appears to form an additional interaction with the N-terminal end of the middle domain of HSP101 protomer 1 (Extended Data Fig. 8d ). The middle domain is known to have a critical role in regulating ATPase and unfoldase activities in related HSP100s 35, 36 , suggesting that this interaction is of high functional importance.
Two observed states suggest a translocation mechanism
In addition to the extended 195 Å engaged state of PTEX, we also observed a more compact 175 Å resetting state. Much of PTEX150(S668-D823) and EXP2 remain unchanged between the engaged and resetting states; a hinge-like swinging motion in the HSP101 hexamer accounts for the 20 Å difference in height. The transmembrane domain and B1-B3 helices of EXP2 exhibit C7 symmetry, and remain identical between the two states (Supplementary Video 6). The deviations from C7 symmetry in the B4-B5 helices and assembly domain are less pronounced in the resetting state (Extended Data Fig. 3b , c), probably owing to the more planar arrangement of HSP101 protomers. As in the engaged state, slight inter-protomer variations in the H2-H3 region of PTEX150(S668-D823) bridge the gap between EXP2 and HSP101, maintaining a continuous protected path for unfolded cargo proteins.
The spiral staircase of HSP101 tyrosine pore loops in the engaged state collapses into a planar C shape in the resetting state ( Supplementary Video 7) , with a freedom of movement possibly conferred by the gap between HSP101 protomers 1 and 6 30, 31 . Starting at the interface between the NBD2 domains of HSP101 protomers 3 and 4, HSP101 protomers 4-6 swing downwards and outwards, creating a deep vertical cleft through the central pore of the hexamer. and dark (NBD2) blue gradients to emphasize the right-handed spiral shape of the hexamer. The bisected map shows NBD2 pore loop densities coloured by protomer, ATPγS (magenta) and the cargo density (light pink). d, Enlarged side view of the atomic models of the HSP101 NBD2 pore loops and unfolded cargo polypeptide backbone, shown with densities. NBD2 pore loops are coloured as in c and labelled by protomer (for example, D2PL,P1 is NBD2 pore loop, protomer 1). Vertical distances between pore loop tyrosines in D2PL,P1-D2PL,P6 are 6.52 Å, 6.28 Å, 6.38 Å, 6.96 Å and 6.12 Å, respectively. 
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This movement pulls the NBD2 loops in protomers 4-6 away from the unfolded cargo (Extended Data Fig. 3d , e, h, i, Supplementary Videos 6, 7). A shorter (19 Å versus 45 Å), unfolded cargo density remains visible, bound to the NBD2 loops in protomers 1-3, whereas no peptide density is visible in protomers 4-6 ( Fig. 6a , Extended Data Fig. 3h , i). Furthermore, the NBD1 domain of protomer 3 rotates outward, such that the R361 arginine finger remains within 5.2 Å of the ATPγS bound to NBD1 of protomer 4, and the nucleotide in NBD2 of protomer 4 shifts 7.5 Å away from the R859 arginine finger in protomer 3 (Extended Data Fig. 3f , g).
Discussion
We propose a PTEX-mediated mechanism of protein translocation via a cyclic process involving at least two discrete states ( Fig. 6b , Supplementary Videos 6, 7), which we have captured by purifying PTEX complexes directly from P. falciparum that are actively translocating cargo. The pore loops in HSP101 NBD2 form two 'hands' that work together to thread the cargo protein through the central pore. NBD2 loops from HSP101 protomers 1-3 form the passive hand, located closest to the PTEX150(S668-D823)-EXP2 funnel, which remains fixed between states (Fig. 6a, b ). NBD2 loops from HSP101 protomers 4-6 form the active hand, which moves along the channel axis (above the passive hand), grasping the unfolding peptide and feeding it through the passive hand. In the engaged state, all six NBD2 pore loops grip the unfolded peptide in the spiral staircase formation (Fig. 6a, b ). As the HSP101 hexamer collapses into the resetting state, the active hand moves downwards, feeding the newly unfolded peptide through the passive hand, into the PTEX150(S668-D823)-EXP2 funnel below. The passive hand then grips the unfolded peptide, preventing it from slipping back towards the HSP101 apical entrance while the active hand swings outward, releasing the cargo (Fig. 6a, b) . Finally, the active hand moves upwards to grasp the unfolding protein further upstream, transitioning back to the engaged state. This cyclic feeding mechanism threads the unfolded cargo protein through the translocon, across the PVM and into the cytosol of the host cell.
The states captured here may be two of several states in the processive phase of translocation. Additional states are likely to exist for cargo recognition. Although we did not observe PTEX-free HSP101 oligomers as has been suggested 37 , we did observe additional, seemingly cargo-free PTEX complexes (Extended Data Fig. 9 ) that did not refine to better than 7 Å, suggesting that there is conformational heterogeneity in the absence of stabilizing cargo interactions. Cargo-PTEX interactions during cargo recognition may be transient, possibly explaining why we did not observe the N-terminal domains of HSP101, or other components that are potentially required for cargo recognition. Without these details, the mechanisms of cargo recognition and subsequent refolding after translocation remain unclear, although there is some evidence for the involvement of exported parasite chaperones 38 or co-opted host chaperonins 39 in these processes. Of note, on the basis of secondary structure prediction and PTEX150 truncation experiments 37 , PTEX150 residues D838-F912 may occupy the claw (PTEX150 residues D838-E873) and three-turn helix (PTEX150 residues S884-F912) densities that remain unassigned in our structures.
Our work demonstrates the advantages of obtaining structures of challenging protein complexes in functionally relevant states by imaging samples purified directly from endogenous sources. Direct observation of the native PTEX core provides compelling evidence that this complex containing EXP2, PTEX150 and HSP101 is a bona fide translocon that is embedded in the PVM and serves as the gateway for the malaria parasite exportome. In addition to establishing the role of EXP2 as the membrane-spanning pore of PTEX and providing insight into the mechanism of this essential protein translocating machine, our structures reveal an interaction between the EXP2 assembly domain and the C-terminal domain of HSP101 that is indispensable for PTEX function. These atomic structures of PTEX provide potential targets for designing a new class of drugs to inhibit this essential gatekeeper of the malarial exportome.
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MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Cells. P. falciparum strain NF54 attB was obtained from the Fidock laboratory where it was generated 41 and was used exclusively in the study. De-identified, IRB-exempt expired RBCs were obtained from the blood bank at the St. Louis Children's Hospital. PCR amplified regions from the NF54 attB genome were found to match the genome sequence for 3D7, a sub clone of NF54. The presence of the cg6 localized attB sequence was verified by successful Bxb1-mediated integration at that site. Cell lines were not tested for mycoplasma contamination. P. falciparum culture and genetic modification for PTEX purification. P. falciparum culture was performed as described 42 with the exception that RPMI was supplemented with 0.5% Albumax I. All plasmid construction was carried out by infusion cloning (Clontech) unless otherwise noted. Integration of a 3×Flag fusion at the endogenous HSP101 C terminus was accomplished with CRISPR-Cas9 editing. A Cas9 target site was chosen just upstream of the hsp101 stop codon (TAATAGTAAAGCTAAAAACT) and the guide RNA seed sequence was synthesized as a sense and anti-sense primer pair (sense shown) 5′-TAAGTATATAATATTTAATAGTAAAGCTAA AAACTGTTTTAGAGCTAGAA-3′, annealed and inserted into the BtgZI site of the plasmid pAIO 43 , resulting in the plasmid pAIO-HSP101-CT-gRNA1. A 5′-homology flank (up to but not including the stop codon) was amplified from P. falciparum NF54 attB genomic DNA using primers 5′-GACGCGAGGAAA ATTAGCATGCATCCTTAAGGAGATTCTGGTATGCCACTTGGTTC-3′ and 5′-CTGCACCTGGCCTAGGGGTCTTAGATAAGTTTATAACTAAGTTTTTA GCTTTACTATT-3′, incorporating a synonymous shield mutation in the protospacer adjustment motif of the gRNA target site within the hsp101 coding sequence. A 3′-homology flank (beginning 3 bp downstream of the stop codon) was amplified using primers 5′-CACTATAGAACTCGAGAATTACGCATATAT ATATATATATATATATATAACATGGGTTG-3′ and 5′-GAACCAAGTGGCA TACCAGAATCTCCTTAAGGATGCATGCTAATTTTCCTCGCGTC-3′. The flank amplicons were assembled in a second PCR reaction using primers 5 ′-C AC TA TA GA AC TC GA GA AT TA CG CA TA TA TA TA TA TA TA TA TATATATAACATG GGTTG-3′ a nd 5′-C TG CA CC TG GC CT AG GG GT CT TA GA TA AG TT TA TA AC TA AG TTTTTAGCTTTACTATT-3′ and inserted between XhoI and AvrII in pPM2GT 42 . The GFP tag between AvrII and EagI in this vector was then replaced with sequence encoding a 3×Flag tag using the primer 5 ′-C TT AG TT AT AA AC TT AT CT AA GA CC CC TA GG GA CT AC AA GG AC GA CG AC GA CA A G GA TT AT AA AG AT GA TG AT GA TA AA GA TT AT AA AG AT GA TGATGATAAA TGACGGCCGCGTCGAGTTATATAATATATTTATG-3′ and a QuikChange Lightning Multi Site-Directed Mutagenesis kit (Agilent), resulting in the plasmid pPM2GT-HSP101-3×Flag. This plasmid was linearized at the AflII site between the 3′ and 5′-homology flanks and co-transfected with pAIO-HSP101-CT-gRNA1 into P. falciparum NF54 attB parasites 41 . Selection with 10 nM WR99210 was applied 24 h after transfection. Once P. falciparum returned from selection, integration at the intended site was confirmed by PCR with primers 5′-CGAAAACTTTTATGGTATTAATATAACAG-3′ and 5′-CCTTGTCGTCGTCGTCCTTG-3′ and a clonal line was isolated by limiting dilution.
For PTEX purification, P. falciparum expressing HSP101-3×Flag were synchronized by serial treatment with 5% w/v d-sorbitol and then expanded while shaking to increase singlet invasion events and maintain synchrony. For each preparation, ~2 × 10 10 erythrocytes infected with P. falciparum were collected at the ring stage (typically ~500 ml 2% haematocrit culture at ~20% parasitaemia). Erythrocytes were lysed in 10× pellet volume of cold phosphate-buffered saline (PBS) containing 0.0125% saponin (Sigma, sapogenin content ≥ 10%) and EDTA-free protease inhibitor cocktail (Roche or Pierce). Released P. falciparum were washed in cold PBS containing EDTA-free protease inhibitor cocktail and washed cell pellets were frozen in liquid nitrogen and stored at −80 °C. Affinity purification of PTEX core complex from P. falciparum pellets. Frozen P. falciparum pellets were resuspended in lysis buffer (25 mM HEPES pH 7.4, 10 mM MgCl 2 , 150 mM KCl, 10% glycerol) and homogenized using a glass Dounce tissue homogenizer. The membrane fraction was isolated from the homogenized lysate by centrifugation at 100,000g for 1 h. The membrane pellet was solubilized in solubilization buffer (25 mM HEPES pH 7.4, 10 mM MgCl 2 , 150 mM KCl, 10% glycerol, 0.4% triton X-100) and the solubilized membranes were then applied to anti-Flag M2 affinity gel resin (Sigma). The resin was washed extensively in wash buffer (25 mM HEPES pH 7.4, 10 mM MgCl 2 , 150 mM KCl, 10% glycerol, 0.015% triton X-100), after which the protein was eluted from the affinity resin with elution buffer (25 mM HEPES pH 7.4, 10 mM MgCl 2 , 150 mM KCl, 2 mM ATPγS, 0.015% triton X-100, 500 µg/ml Flag peptide).
The presence and relative abundance of the three PTEX core components were verified by silver stained SDS-PAGE and tryptic digest liquid chromatography-mass spectrometry (Extended Data Fig. 1e, f ). The extremely low yields achievable when purifying PTEX directly from P. falciparum prohibited the conventional approach of evaluating sample quality by size exclusion chromatography. Thus, during the iterative process of screening for optimal purification conditions, sample quality was assessed by negative stain (uranyl acetate) transmission electron microscopy in an FEI TF20 microscope equipped with a TVIPS 16 mega-pixel CCD camera. In brief, small datasets of ~100,000 particles were collected and 2D class averages were generated in RELION 44, 45 to assess the presence of sufficient numbers of intact PTEX particles yielding 'good' class averages exhibiting distinct features. For example, C7 symmetry could be recognized in top views, and the characteristic Clp/HSP100 layers were visible in side views (Extended Data Fig. 6a-c) . Cryo-electron microscopy. Three-microlitre aliquots of purified PTEX core complex were applied to glow-discharged lacey carbon grids with a supporting ultrathin carbon film (Ted Pella). Grids were then blotted with filter paper and vitrified in liquid ethane using an FEI Vitrobot Mark IV or a home-made manual plunger. Cryo-EM grids were screened in an FEI Tecnai TF20 transmission electron microscope while optimizing freezing conditions.
Higher resolution cryo-EM images were collected on a Gatan K2-Summit direct electron detector in counting mode on an FEI Titan Krios at 300 kV equipped with a Gatan Quantum energy filter set at a 20 eV slit width. Fifty frames were recorded for each movie at a pixel size of 1.04 Å at the specimen scale, with a 200-ms exposure time and an average dose rate of 1.2 electrons per Å 2 per frame, resulting in a total dose of 60 electrons per Å 2 per movie. The final dataset consists of a total of 25,000 movies recorded in four separate sessions. Image processing and 3D reconstruction. Frames in each movie were aligned, gain reference-corrected and dose-weighted to generate a micrograph using MotionCor2 46 . Aligned and un-dose-weighted micrographs were also generated and used for contrast transfer function (CTF) estimation using CTFFIND4 47 and PTEX particle picking by hand and using Gautomatch (https://www.mrc-lmb.cam. ac.uk/kzhang/Gautomatch/Gautomatch_Brief_Manual.pdf).
In total, 1,508,462 particles were extracted from 19,752 micrographs and initially binned by a factor of 2. After two rounds of reference-free two-dimensional (2D) classification in RELION, 422,713 particles were selected as 'good' particles from distinct 2D class averages representing different views of the PTEX core complex. These particles were then used in a one-class ab initio reconstruction followed by homogeneous refinement in CryoSPARC 48 , yielding a 4.8 Å ab initio 3D map.
The original 422,713 'good' particles were then aligned in a 3D refinement in RELION using the 4.8 Å CryoSPARC map as an initial reference. All subsequent image-processing steps were performed using RELION. After this refinement, the particles were unbinned, their centres recalculated and used to re-extract particles from the original micrographs without binning. The newly extracted, unbinned particles were then aligned with a second 3D refinement yielding a ~4.5 Å reconstruction.
An exhaustive, iterative search of classification and refinement conditions was used to sort out different conformations and further improve resolution (Extended Data Fig. 9 ). In brief, upon further sorting using 3D-classification without alignment, we identified two homogenous particle subsets corresponding to the engaged and resetting states (Extended Data Fig. 9 ). Particles in the two subsets were refined separately, yielding full maps with overall resolutions of 4.16 Å and 4.23 Å, respectively.
Focused 3D classification without alignment followed by focused refinement was used to further improve the resolution of mobile regions of the structure in both states. C7 symmetry was applied in the focused 3D classification and refinement steps of the heptameric halves, comprising EXP2 and PTEX150, yielding a 3.4 Å engaged state map and a 3.5 Å resetting state map (Extended Data Figs. 3, 9) . The same procedure, except with C1 symmetry, was applied to the hexameric half of the engaged state, yielding a 4.09 Å map (Extended Data Figs. 3, 9 ). This last step was also applied to the hexameric half of the resetting state, but did not yield improvements in resolution. Further efforts of focused 3D classification and refinement of individual HSP101 protomers, individual claws, and HSP101 N-terminal domain densities in the two states did not ultimately yield improvements in resolution in either state. Model building and refinement. Map interpretation was performed with UCSF Chimera 49 and COOT 50 . P. falciparum protein sequences were obtained from the National Center for Biotechnology Information (NCBI) 51 and the PlasmoDB 52 protein databases. PHYRE2 53 secondary structure predictions were used as an aid for initial manual sequence registration. Models for a single monomer of HSP101, PTEX150, and EXP2 in the engaged state were all built de novo. This first model for each protein monomer was then placed into the density maps of other protomers to aid de novo modelling of subsequent protomers. Individual protomers in the complex were then manually remodelled to ensure a close fit between densities and models. The same process was repeated for the resetting state. Manual refinement targeting protein geometry alone was done primarily along the periphery and flexible regions of the complex (for example, the M domains of HSP101). Whereas their densities and backbone traces were visible, we were unable to model the claw with its connected three-turn helix, nor one of the 12 M domain loops in the resetting state (Fig. 5g, h) . The three-turn helix displayed a few bulky side chains interacting with the M domain of HSP101; however, the lack of backbone connection to our atomic model of the complex and the limited visibility of smaller side chains in this region made sequence assignment challenging.
Manual refinement targeting both protein geometry and fit with the density map was used primarily in the core regions where resolution was higher and noise was minimal. Rotamers were fitted manually in COOT and improved using the 'back-rub rotamers' setting. The resulting models for the complexes were subjected to the phenix.real_space_refine program in PHENIX 54 . Following this step, Molprobity 55 reported less than ideal clash scores and map-to-model cross-correlation. To improve the geometry and fit, manual adjustments were made to protein geometry and density map fit, with the additional step of using Molprobity 55 clash dots and sphere-refinement in COOT.
The complex was then broken into three portions: (1) symmetric regions of EXP2 and PTEX150, (2) HSP101, and (3) the full PTEX complex. These model segments were fed back to phenix.geometry_minimization in PHENIX and then to phenix.real_space_refine using simulated annealing and global minimization applying Emsley's Ramachandran restraints 50 . Following another round of manual checks and improvements, all models were subjected to phenix.real_space_refine with default settings one last time.
All figures and videos were prepared with UCSF Chimera, Pymol (https://www. pymol.org), and Resmap 56 . Molprobity was used to validate the stereochemistry of the final models. Genetic complementation. For expression of a complementing second copy of truncated EXP2, the exp2 coding sequence up to codon position 221 was amplified with primers 5′-CGAATAAACACGATTTTTTCTCGAGATGAAAGTCAGTT ATATATTTTCCTTTTTTTTGTTATTCTTCG-3′ and 5′-AATCAACTT TTGTTCGCTAGCTTTCTTTGATTCCATAGATTTCAATTTCTCTTCC-3′ and inserted into the plasmid pyEOE-attP-EXP2-3×Myc 20 between XhoI and NheI, resulting in the plasmid pyEOE-attP-EXP2∆222-287-3×Myc. This plasmid was co-transfected with pINT 41 into EXP2 apt ::HSP101-3×Flag conditional knockdown parasites 20 at the mature schizont stage using a Nucleofector 2b and Basic Parasite Nucleofector kit 2 (Lonza). Selection with 2 µM DSM1 57 was applied 24 h post-transfection (in addition to 2.5 µg/ml blasticidin S and 1 µM anhydrotetracycline for maintenance of endogenous EXP2 translational control by the aptamer system) to facilitate integration into the attP site engineered in the benign cg6 locus through integrase mediated attB × attP recombination. Following return from selection, P. falciparum were cloned by limiting dilution, and expression of EXP2(∆222-287)-3×Myc was confirmed by western blot. P. falciparum growth assays. EXP2 apt ::EXP2(∆222-287) P. falciparum were extensively washed to remove aTc and plated with or without 1 µM aTc in triplicate at an initial parasitaemia of 1%. The medium was changed every 48 h and 1:1 subculture was performed every other day beginning on day 4 to avoid culture overgrowth. Parasitaemia (percentage of total red blood cells (RBCs) infected) was measured every 24 h by flow cytometry on a FACSCanto (BD Biosciences) by nucleic acid staining of cultured RBCs with PBS containing 0.8 µg/ml acridine orange. Cumulative parasitaemias were back calculated based on the subculture schedule and data were fitted to an exponential growth equation to determine rate constants using Prism (Graphpad). Quantification of protein export. For evaluation of protein export by immunofluorescence assay (IFA), mature schizonts were purified on a magnetic column and allowed to invade fresh, uninfected RBCs with shaking for 3 h before treatment with 5% w/v d-sorbitol to destroy unruptured schizonts. Pulse-invaded cells were plated with or without 1 µM aTc and allowed to develop 24 h post-invasion. Thin smears of infected RBCs were briefly air dried and immediately fixed in ice-cold acetone for 2 min. After fixation, samples were blocked for 30 min in PBS + 3% BSA followed by incubation for 1 h with primary antibody solutions containing mouse anti-Flag M2 monoclonal antibody (detecting HSP101-3×Flag to mark the PVM) and rabbit anti-SBP1. After washing, secondary antibody incubation was carried out for 1 h with Alexa Fluor anti-mouse 488 and anti-rabbit 594 IgG antibodies (Life Technologies), each diluted 1:2,000. After final washing, coverslips were mounted over each sample using Pro-long antifade Gold with DAPI (Life Technologies). Images were collected with an ORCA-ER CCD camera (Hamamatsu) using AxioVision software on an Axio Imager.M1 microscope (Zeiss) with a 100× oil-immersion objective using the same exposure times for each image (300 ms for SBP1-594, 150 ms for Flag-488). Ten images were acquired for each condition using the DAPI channel for field selection to avoid bias. Images were then analysed using Volocity 6.3 (PerkinElmer). The border of each singleinfected erythrocyte was traced using the DIC channel as a guide to define a region of interest (ROI). The PVM was marked using the 'find objects' measurement tool for the HSP101-3×Flag-488 channel (automatic threshold setting with threshold offset set to −30% and minimum object size set to 0.5 µm 2 ). Individual Maurer's clefts were identified using the 'find spots' measurement tool for the SBP1-594 channel (offset minimum spot intensity set to 40% and brightest spot within radius set to 0.5 µm). All spots within the PVM object boundary were then removed using the 'subtract' measurement tool and the number and fluorescent intensity of the remaining spots in each ROI were collected. Data were pooled from two independent experiments and plotted with Prism. Antibodies. The following primary antibodies were used for IFA and western blot: mouse anti-Flag monoclonal antibody clone M2 (Sigma) (IFA, 1:500; western blot, 1:500); rabbit polyclonal anti-SBP1 58 (IFA, 1:500); mouse anti-cMYC monoclonal antibody 9E10 (ThermoFisher) (western blot, 1:300). Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Data availability. The atomic models have been deposited to the Protein Data Bank under accession numbers 6E10 and 6E11 and the cryo-EM density maps have been deposited in the Electron Microscopy Data Bank under accession numbers EMD-8951 and EMD-8952.
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Extended Data Fig. 1 | Generation of HSP101-3×Flag P. falciparum and analysis of purified PTEX. a, Schematic showing strategy for endogenous tagging of P. falciparum hsp101 with 3×Flag using CRISPR-Cas9 editing. Diagnostic PCR primers and expected amplicon following successful integration are shown. sgRNA, single-guide RNA; UTR, untranslated region; CAM, calmodulin promoter; PfU6, P. falciparum U6 promoter; hDHFR, human dihydrofolate reductase. b, Diagnostic PCR with genomic DNA template from NF54 attB parent or two independent populations of HSP101-3×Flag P. falciparum. The experiment was performed once. c, Western blot of NF54 attB and HSP101-3×Flag P. falciparum probed with mouse Flag M2 antibody (Sigma) and goat anti-mouse IRDye 680 secondary antibody (Li-Cor). Arrowhead indicates full-length HSP101-3×Flag (predicted molecular weight 102.9 kDa after signal peptide cleavage). Data represent two independent experiments. d, Giemsa staining of parasite-infected human erythrocytes from which PTEX was purified. Scale bar, 5 µm. For source data, see Supplementary  Fig. 3 . e, Silver-stained SDS-PAGE of the Flag-purified PTEX sample. Identities of the bands labelled EXP2, PTEX150 and HSP101 were confirmed by tryptic digest liquid chromatography-mass spectrometry (LC-MS). f, Tryptic digest LC-MS analysis of the Flag-purified PTEX sample. The PTEX core components are among the five most abundant species detected in the purified sample. For gel and blot source data, see Supplementary Fig. 1 .
Extended Data Fig. 3 | Detailed comparisons of the engaged and resetting states. a, Side and top views of the EXP2 heptamer in the engaged state. Symmetric portions that remain constant between protomers are coloured in mint. Portions that vary between protomers are coloured and labelled by protomer. b, c, Superposition of the seven EXP2 protomers, labelled A-G, in the engaged (b) and resetting (c) states, coloured as in a. d, e, Top view of HSP101 NBD1 (d) and NBD2 (e) in the engaged and resetting states, shown in simplified surface representation. The hinge point at the interface between HSP101 protomers 3 and 4 is indicated. f, g, Ribbon diagrams of the resetting state (f) and engaged state (g) nucleotide binding pockets are shown for each protomer. ATPγS in each pocket is shown with corresponding cryo-EM density (mesh). The R859 arginine finger (sidechain shown in red-orange) is positioned approximately 3-5.5 Å from the phosphorus atom in the γ-phosphate of the ATPγS in the binding pocket of the neighbouring protomer in all protomers except R859 in protomer 3 in the resetting state (sidechain shown in gold), where the ATPγS bound in the protomer 4 NBD2 nucleotide pocket has shifted approximately 7.5 Å away from the protomer 3 R859 arginine finger. h, i, Enlarged side view of the atomic models of the HSP101 NBD2 pore loops and unfolded cargo polypeptide backbone in the engaged (h) and resetting (i) states, shown with corresponding cryo-EM densities. Tyrosine sidechain densities are clearly visibly intercalating with the cargo densities. The modelled PTEX cargo has a calculated r.m.s.d. of 1.09 Å and 1.25 Å to the published YME1 and HSP104 cargo models, respectively. Pore loops are labelled by NBD and protomer (for example, D2PL,P1 is NBD2 pore loop, protomer 1).
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Data analysis
Gautomatch, MotionCor2, CTFFIND4, RELION1.4, RELION2.0, CryoSparc, HOLE, Pymol, UCSF Chimera, Resmap, Molprobity, Coot, PHENIX , Prism (Graphpad), Volocity (Perkin Elmer) For manuscripts utilizing custom algorithms or software that are central to the research but not yet described in published literature, software must be made available to editors/reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). See the Nature Research guidelines for submitting code & software for further information.
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The atomic models and the cryoEM density maps will be deposited to the Protein Data Bank and the Electron Microscopy Data Bank, under the accession numbers of 6E10, 6E11, EMD-8952 and EMD-8951, respectively.
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Sample size 3D reconstructions were calculated from thousands of particle images. This number was determined based on resolutions measured by the Resmap program to be ~2.8-4.5 angstroms, with visible densities for different amino acid residue sidechains.
Data exclusions about 67% of the total particle images were discarded after 2D and 3D classification using the program RELION.
Replication
Parasite growth and export assay data was collected from cells cultured in two different donor blood samples in experiments performed independently. All attempts at replication were successful.
Randomization In parasite growth and export assays, samples were + or -aTc treatment to facilitate expression or knockdown of exp2, respectively. In export assays, individual cells analyzed in these conditions were selected by choosing fields using DAPI stain (blind to the experimental channels). All single infected cells in each chosen field were incorporated into the analysis as described in the methods.
Blinding
Immuno fluorescence image acquisition for export assays was performed blind to the experimental channels using the DAPI channel as described in the methods.
Reporting for specific materials, systems and methods 
Antibodies
Antibodies used
The following primary antibodies were used for IFA and western blot: mouse anti-FLAG mAb clone M2 (Sigma, catalog # F1804) (IFA: 1:500, WB 1:500); rabbit polyclonal anti-SBP1 [Ref 59] (IFA: 1:500); mouse anti-cMYC mAb 9E10 (ThermoFisher catalog # 13-2500) (WB: 1:300). The following secondary antibodies were used for IFA and western blot: Alexa Fluor Goat anti-Mouse 488 IgG (ThermoFisher catalog # A11029) (IFA: 1:2,000); Alexa Fluor Goat anti-Rabbit 594 IgG (ThermoFisher catalog # A11037) (IFA: 1:2,000); IRDye 680RD Goat anti-Mouse IgG (Li-cor catalog # 925-68070) (WB: 1:10,000); IRDye 800CW Goat anti-Mouse IgG (Licor catalog # 925-32210) (WB: 1:10,000). Lot numbers are not available for commercial antibodies.
Validation
For antibodies against epitope tags, untagged parental parasite lines were used to validate specificity in western blot as shown in Figure 4 and Extended Data Figure 1 . The antibody against the unique parasite antigen SBP1 has been previously validated: see references 59 and 12.
